Clinical Trials Directory

Trials / Terminated

TerminatedNCT03743961

Geriatric Intervention Contribution on Quality of Life of Elderly Patients With Metastatic Neoplasia

Description the Geriatric Intervention Contribution on Quality of Life of Elderly Patients With Metastatic Neoplasia : Prospective Descriptive Non-comparative Cohort ( QUALI Cohort)

Status
Terminated
Phase
Study type
Observational
Enrollment
28 (actual)
Sponsor
Institut de Cancérologie de la Loire · Academic / Other
Sex
All
Age
75 Years
Healthy volunteers

Summary

The aim of this study is to describe the impact of : Geriatric intervention contribution on quality of life of elderly patients receiving systemic treatments for metastatic neoplasia

Detailed description

Elderly cancer incidence increases exponentially with advancing age. However, elderly patients are largely underrepresented in cancer treatment trials. The geriatric population presents particular physical, mental, psychological or social specificities that may condition the prognosis especially for patients with metastatic neoplasia. Recently, the measurement of quality of life (QoL) in aging population is being recognized as an important part of clinical decision. It is therefore essential to set up prospective studies to evaluate the impact of oncogeriatric practices on the quality of life of elderly patients with metastatic neoplasia. The main objective of this prospective study is to describe the contribution of geriatric intervention on quality of life for for elderly (\> 75 years) with metastatic solid cancer receiving systemic treatment during the first 6 months of their therapeutic management.

Conditions

Interventions

TypeNameDescription
OTHERgeriatric interventionGeriatric intervention

Timeline

Start date
2018-11-21
Primary completion
2020-07-02
Completion
2020-07-02
First posted
2018-11-16
Last updated
2020-07-07

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03743961. Inclusion in this directory is not an endorsement.